FR2508904B2 - Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant - Google Patents

Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant

Info

Publication number
FR2508904B2
FR2508904B2 FR8122143A FR8122143A FR2508904B2 FR 2508904 B2 FR2508904 B2 FR 2508904B2 FR 8122143 A FR8122143 A FR 8122143A FR 8122143 A FR8122143 A FR 8122143A FR 2508904 B2 FR2508904 B2 FR 2508904B2
Authority
FR
France
Prior art keywords
nitrogen
immunoregulator
inflammatory
pharmaceutical composition
composition containing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8122143A
Other languages
English (en)
Other versions
FR2508904A2 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2508904A2 publication Critical patent/FR2508904A2/fr
Application granted granted Critical
Publication of FR2508904B2 publication Critical patent/FR2508904B2/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/26—Radicals substituted by halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/32—Sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR8122143A 1981-06-26 1981-11-26 Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant Expired FR2508904B2 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/276,242 US4371696A (en) 1980-07-14 1981-06-26 Certain pyridine methylthio acetaldehyde derivatives and non-cyclic and cyclic acetals thereof

Publications (2)

Publication Number Publication Date
FR2508904A2 FR2508904A2 (fr) 1983-01-07
FR2508904B2 true FR2508904B2 (fr) 1985-11-29

Family

ID=23055809

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8122143A Expired FR2508904B2 (fr) 1981-06-26 1981-11-26 Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant

Country Status (22)

Country Link
US (1) US4371696A (fr)
JP (1) JPS58916A (fr)
AU (1) AU528433B2 (fr)
BE (1) BE890374R (fr)
CH (1) CH648483A5 (fr)
DE (1) DE3215648A1 (fr)
FR (1) FR2508904B2 (fr)
GB (1) GB2100600B (fr)
GR (1) GR75753B (fr)
HK (1) HK67087A (fr)
IE (1) IE51727B1 (fr)
IL (1) IL63699A0 (fr)
IT (1) IT1200569B (fr)
KE (1) KE3458A (fr)
LU (1) LU83827A1 (fr)
MY (1) MY8500351A (fr)
NL (1) NL8105744A (fr)
NZ (1) NZ198215A (fr)
PH (1) PH17742A (fr)
SE (1) SE442110B (fr)
SG (1) SG56084G (fr)
ZA (1) ZA821139B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6179685U (fr) * 1984-10-26 1986-05-27
JPS61207304A (ja) * 1985-03-11 1986-09-13 Toyo Soda Mfg Co Ltd 農園芸用殺菌剤
JPH0445817Y2 (fr) * 1988-09-09 1992-10-28
US5610198A (en) * 1994-03-18 1997-03-11 The United States Of America As Represented By The Department Of Health And Human Services Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3558640A (en) * 1967-12-20 1971-01-26 Merck & Co Inc Certain pyridyl and thiazolyl methylthiopropionic acids and derivatives
GB1434271A (en) * 1972-09-28 1976-05-05 Squibb & Sons Inc Cephalosporins
US4246263A (en) * 1979-10-15 1981-01-20 Pfizer Inc. Antiinflammatory and immunoregulatory pyrimidines, their method of use and pharmaceutical compositions

Also Published As

Publication number Publication date
KE3458A (en) 1984-10-12
IE812748L (en) 1982-12-26
GB2100600A (en) 1983-01-06
NZ198215A (en) 1984-07-06
GB2100600B (en) 1983-09-14
LU83827A1 (fr) 1982-05-07
HK67087A (en) 1987-09-25
IL63699A0 (en) 1981-11-30
GR75753B (fr) 1984-08-02
US4371696A (en) 1983-02-01
MY8500351A (en) 1985-12-31
ZA821139B (en) 1983-01-26
NL8105744A (nl) 1983-01-17
AU528433B2 (en) 1983-04-28
IE51727B1 (en) 1987-03-04
IT8219162A0 (it) 1982-01-18
CH648483A5 (fr) 1985-03-29
PH17742A (en) 1984-11-27
BE890374R (fr) 1982-03-16
SG56084G (en) 1985-03-08
JPS58916A (ja) 1983-01-06
IT1200569B (it) 1989-01-27
SE442110B (sv) 1985-12-02
SE8107101L (sv) 1982-12-27
FR2508904A2 (fr) 1983-01-07
DE3215648A1 (de) 1983-01-13

Similar Documents

Publication Publication Date Title
BE867727A (fr) Nouveaux composes de phtalazine et composition pharmaceutique les contenant
BE859824A (fr) Nouveaux derives d'hydantoine et composition pharmaceutique les contenant
DK330287D0 (da) Antiinflammatorisk forbindelse og farmaceutisk sammensaetning indeholdende samme
FR2586562B1 (fr) Composition pharmaceutique contenant de l'a-methylhistamine
BE876732A (fr) Nouveaux aminothiazoles et composition pharmaceutique les contenant
FR2582513B1 (fr) Compositions pharmaceutiques contenant de l'alfuzosine
BE873500A (fr) Nouveaux derives de thienohydantoine et composition pharmaceutique les contenant
FR2559061B1 (fr) Compositions analgesiques et anti-inflammatoires contenant de la diphenhydramine
KR870700608A (ko) 아미노-살리실산 유도체 및 제약 조성물
BE892805A (fr) Cycloalcanes substitues et compositions pharmaceutiques les contenant
FR2626002B1 (fr) Nucleosides dideoxydidehydrocarbocycliques et composition pharmaceutique les contenant
MC1695A1 (fr) Procedes de preparation de nouveaux composes et de formes pharmaceutiques les contenant
BE887970A (fr) Nouveaux derives d'ocytocine et compositions pharmaceutiques contenant ces derives
NL193217B (nl) 1-Methyl-5-p-toluoyl-2-pyrroolaceetamidederivaat met ontstekingsremmende en analgetische eigenschappen en farmaceutisch preparaat dat het bevat.
FR2626175B1 (fr) Composes nouveaux de 1,2-ethylenediamine et composition pharmaceutique les contenant
BE885709A (fr) Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant
IT1195324B (it) Derivati encefalinici dotati di attivita' analgesica e composizioni farmaceutiche che li contengono
BE885389A (fr) Composes penam acetoxymethyles et composition pharmaceutique les contenant
IL80583A0 (en) Cardiotonic heterocyclic oxazolones and pharmaceutical compositions containing them
FR2331339A1 (fr) Nouveaux composes heterocycliques et composition pharmaceutique les contenant
FR2508904B2 (fr) Nouveaux composes heterocycliques azotes anti-inflammatoires et immunoregulateurs et composition pharmaceutique les contenant
FR2528425B1 (fr) 1,4-dihydropyridines et composition pharmaceutique les contenant
NO862606L (no) Forbedring av komposittmaterialer
BE883749A (fr) Beta-octamolybdate d'ammelinium et compositions le contenant
IT1210582B (it) Derivati di acido 4-fenil-4-ossobuten-2-oico dotati di proprieta'farmacologiche e composizioni farmaceutiche che li contengono